Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
Reach Us
+44 1223 790975
GET THE APP
The Importance Of Genetic Testing In Pediatric Epilepsy | 107420
ISSN: 2161-0460
Journal of Alzheimers Disease & Parkinsonism
Open Access
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Background and Objective: Epilepsy is a very common medical problem worldwide, affecting 0.5-1 percent of
the population. Although there can be multiple etiologies for seizures, such as brain malformations or traumatic
brain injury, it is increasingly recognized that genetics plays an important role in epilepsy. Testing options include
chromosomal microarrays, epilepsy panels, and whole Exome sequencing. Genetic causes of epilepsy are many,
but include mutations in ion transporters or channels, neurotransmitter receptors, metabolic disorders, and many
others. The discovery of a genetic etiology can have profound impacts on treatment decisions, recurrence risk,
and prognosis, and thus testing should be considered in all patients with an otherwise unexplained cause for their
seizures.
Study Design: More than 100 patients with epilepsy were tested by a combination of chromosomal microarrays,
epilepsy panels, and whole Exome sequencing as part of their evaluation for recurrent seizures. Additionally, MRI
imaging and EEGs were done, to correlate with seizures and genetic test results. Some patients underwent Vagus
Nerve Stimulation (VNS) placement for refractory seizures with demonstrated benefit above medical therapy alone.
Study Participants and Settings: All patients were between the ages of newborn to 30 years old and seen as inpatients
or outpatients through Tulane University School of Medicine.
Materials and Methods: Samples were collected from > 100 patients with a variety of epilepsy types, and sent for
chromosomal microarray, epilepsy panels, or whole Exome sequencing, depending on the clinical indications. Some
patients with negative microarrays and epilepsy panels were reflexed to whole Exome, to determine if that increased
the yield of detecting abnormalities.
Results: A variety of pathogenic mutations were found, some of which had tremendous impact on treatment decisions.
Chromosomal duplications and deletions detected by chromosomal microarray can be rapidly tested for at low cost,
but had a lower yield than epilepsy panels, where genes suspected to be involved with epilepsy are fully sequenced.
Whole Exome sequencing or mitochondrial DNA testing rarely added additional information regarding etiology in
patients without other neurological signs and symptoms such as autism or developmental delay. Additionally, VNS
implantation demonstrated benefit even in young children and those with generalized seizures, with both reductions
in seizures and improvements in behavior and development.
Conclusion: Epilepsy panels were very high yield, followed by chromosomal microarrays and whole Exome
sequencing. Important examples include avoiding sodium channel blocking antiepileptic medications in patients
with sodium channel mutations, treatment by Ketogenic diet in patients with CSF glucose transporter mutations,
etc. Furthermore, the fact that some patients with genetic mutations associated with severe epilepsy phenotypes
that were refractory to multidrug therapy were responsive to VNS suggests this should be an early consideration in
patients with genetic epilepsies. Early genetic testing can have significant impacts on treatment decisions, and thus
should be strongly considered in patients with epilepsy, especially those that are refractory to medications or who
have comorbid conditions such as autism or developmental delay.
Biography
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals